Advances in mechanisms, imaging and management of the unstable plaque

Atherosclerosis

Volumn 233, Issue 2, 2014, Pages 467-477

  Niccoli, Giampaolo ^a   Liuzzo, Giovanna ^a   Montone, Rocco A ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Acute coronary syndromes; Imaging; Unstable plaque

Indexed keywords

BIOLOGICAL MARKER; VASODILATOR AGENT;

ACUTE CORONARY SYNDROME; ATHEROSCLEROTIC PLAQUE; CARDIAC IMAGING; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; INVASIVE PROCEDURE; NON INVASIVE PROCEDURE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; CARDIOVASCULAR SYSTEM EXAMINATION; CLASSIFICATION; CORONARY ARTERY DISEASE; CORONARY VASOSPASM; DEATH, SUDDEN, CARDIAC; DIAGNOSTIC IMAGING; GENE EXPRESSION PROFILING; IMMUNOLOGY; INFLAMMATION; MACROPHAGE; MONOCYTE; MULTIMODAL IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PLAQUE, ATHEROSCLEROTIC; PROGNOSIS; RUPTURE; T LYMPHOCYTE SUBPOPULATION; VASCULAR CALCIFICATION;

ACUTE CORONARY SYNDROME; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VASOSPASM; DEATH, SUDDEN, CARDIAC; DIAGNOSTIC IMAGING; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; MACROPHAGES; MONOCYTES; MULTIMODAL IMAGING; PLAQUE, ATHEROSCLEROTIC; PROGNOSIS; RUPTURE, SPONTANEOUS; T-LYMPHOCYTE SUBSETS; VASCULAR CALCIFICATION; VASODILATOR AGENTS;

EID: 84896302426     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.01.036     Document Type: Review

References (125)

1. Crea F., Liuzzo G. Pathogenesis of acute coronary syndromes. JAm Coll Cardiol 2013, 61:1-11.
2. Libby P. Mechanisms of acute coronary syndromes. NEngl J Med 2013, 369:883-884.
3. Finn A.V., Nakano M., Narula J., Kolodgie F.D., Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010, 30:1282-1292.
4. Detrano R., Guerci A.D., Carr J.J., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. NEngl J Med 2008, 358:1336-1345.
5. Motoyama S., Kondo T., Sarai M., et al. Multislice computer tomographic characteristics of coronary lesions in acute coronary syndromes. JAm Coll Cardiol 2007, 50:319-326.
6. Motoyama S., Sarai M., Harigaya H., et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. JAm Coll Cardiol 2009, 54:49-57.
7. Rudd J.H., Warburton E.A., Fryer T.D., et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002, 105:2708-2711.
8. Folco E.J., Sheikine Y., Rocha V.Z., et al. Hypoxia but not inflammation augments glucose uptake in human macrophages. Implications for imaging atherosclerosis with FdG-PET. JAm Coll Cardiol 2011, 58:603-614.
9. Veenman L., Gavish M. The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol Ther 2006, 110:503-524.
10. Canat X., Carayon P., Bouaboula M., et al. Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells. Life Sci 1993, 52:107-118.
11. Gaemperli O., Shalhoub J., Owen D.R., et al. Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J 2012, 33:1902-1910.
12. Pugliese F., Gaemperli O., Kinderlerer A.R., et al. Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography. JAm Coll Cardiol 2010, 56:653-661.
13. Garcia-Garcia H.M., Mintz G.S., Lerman A., et al. Tissue characterization using radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting. EuroIntervention 2009, 5:177-189.
14. Stone G.W., Maehara A., Lansky A.J., et al. Aprospective natural-history study of coronary atherosclerosis. NEngl J Med 2011, 364:226-235.
15. Tearney G.J., Yabushita H., Houser S.L., et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003, 107:113-119.
16. Nadkarni S.K., Pierce M.C., Park B.H., et al. Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography. JAm Coll Cardiol 2007, 49:1474-1481.
17. Kume T., Akasaka T., Kawamoto T., et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 2006, 97:1713-1717.
18. Tearney G.J., Regar E., Akasaka T., et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. JAm Coll Cardiol 2012, 59:1058-1072. International Working Group for Intravascular Optical Coherence Tomography (IWG-IVOCT).
19. Jang I.K., Tearney G.J., MacNeill B., et al. Invivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005, 111:1551-1555.
20. Kubo T., Imanishi T., Takarada S., et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. JAm Coll Cardiol 2007, 50:933-939.
21. Uemura S., Ishigami K., Soeda T., et al. Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques. Eur Heart J 2012, 33:78-85.
22. Gardner C.M., Tan H., Hull E.L., et al. Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. JACC Cardiovasc Imaging 2008, 1:638e48.
23. Bourantas C.V., Garcia-Garcia H.M., Naka K.K., et al. Hybrid intravascular imaging: current applications and prospective potential in the study of coronary atherosclerosis. JAm Coll Cardiol 2013, 61:1369-1378.
24. Ambrose J.A., Tannenbaum M.A., Alexopoulos D., et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. JAm Coll Cardiol 1988, 12:56-62.
25. Dacanay S., Kennedy H.L., Uretz E., Parrillo J.E., Klein L.W. Morphological and quantitative angiographic analyses of progression of coronary stenoses. A comparison of Q-wave and non-Q-wave myocardial infarction. Circulation 1994, 90:1739-1746.
26. Little W.C., Constantinescu M., Applegate R.J., et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?. Circulation 1988, 78:1157-1166.
27. Di Lorenzo E., De Luca G., Sauro R., et al. The PASEO (PaclitAxel or Sirolimus- eluting stent versus bare metal stent in primary Angioplasty) randomized trial. JAm Coll Cardiol Intv 2009, 2:515-523.
28. Stone G.W., Lansky A.J., Pocock S.J., et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. NEngl J Med 2009, 360:1946-1959.
29. Frøbert O., van't Veer M., Aarnoudse W., Simonsen U., Koolen J.J., Pijls N.H. Acute myocardial infarction and underlying stenosis severity. Catheter Cardiovasc Interv 2007, 70:958-965.
30. Davies M.J., Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. NEngl J Med 1984, 310:1137-1140.
31. Qiao J.H., Fishbein M.C. The severity of coronary atherosclerosis at sites of plaque rupture with occlusive thrombosis. JAm Coll Cardiol 1991, 17:1138-1142.
32. Narula J., Nakano M., Virmani R., et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. JAm Coll Cardiol 2013, 61:1041-1051.
33. Bugiardini R., Manfrini O., De Ferrari G.M. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med 2006, 166:1391-1395.
34. Niccoli G., Stefanini G.G., Capodanno D., Crea F., Ambrose J.A., Berg R. Are the culprit lesions severely stenotic?. JACC Cardiovasc Imaging. 2013, 6:1108-1114.
35. Davies M.J. The composition of coronary-artery plaques. NEngl J Med 1997, 336:1312-1314.
36. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation 1995, 92:657-671.
37. Fuster V., Fallon J.T., Nemerson Y. Coronary thrombosis. Lancet 1996, 348(Suppl.1):s7-10.
38. Rioufol G., Finet G., Ginon I., et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002, 106:804-808.
39. Mizuno K., Satomura K., Miyamoto A., et al. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. NEngl J Med 1992, 326:287-291.
40. Tanaka A., Imanishi T., Kitabata H., et al. Distribution and frequency of thin-capped fibroatheromas and ruptured plaques in the entire culprit coronary artery in patients with acute coronary syndrome as determined by optical coherence tomography. Am J Cardiol 2008, 102:975-979.
41. Bouki K.P., Katsafados M.G., Chatzopoulos D.N., et al. Inflammatory markers and plaque morphology: an optical coherence tomography study. Int J Cardiol 2012, 154:287-292.
42. Tanaka A., Shimada K., Sano T., et al. Multiple plaque rupture and C-reactive protein in acute myocardial infarction. JAm Coll Cardiol 2005, 45:1594-1599.
43. Kotani J., Mintz G.S., Castagna M.T., et al. Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction. Circulation 2003, 107:2889-2893.
44. Fujii K., Kobayashi Y., Mintz G.S., et al. Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes. Circulation 2003, 108:2473-2478.
45. Burke A.P., Kolodgie F.D., Farb A., et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001, 103:934-940.
46. Di Vito L., Prati F., Arbustini E., Crea F., Maseri A. A"stable" coronary plaque rupture documented by repeated OCT studies. JACC Cardiovasc Imaging 2013, 6:835-836.
47. Mann J., Davies M.J. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 1999, 82:265-268.
48. Yonetsu T., Kakuta T., Lee T., et al. Invivo critical fibrous cap thickness for rupture-prone coronary plaques assessed by optical coherence tomography. Eur Heart J 2011, 32:1251-1259.
49. Liuzzo G., Goronzy J.J., Yang H., et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000, 101:2883-2888.
50. Liuzzo G., Kopecky S.L., Frye R.L., et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 1999, 100:2135-2139.
51. Cristell N., Cianflone D., Durante A., et al. High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study. JAm Coll Cardiol 2011, 58:2654-2661.
52. Libby P., Ridker P.M., Hansson G.K. Inflammation in atherosclerosis: from pathophysiology to practice. JAm Coll Cardiol 2009, 54:2129-2138.
53. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. NEngl J Med 2005, 352:1685-1695.
54. Levi M., van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005, 15:254-259.
55. Croce K., Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr Opin Hematol 2007, 14:55-61.
56. van der Wal A.C., Becker A.E., van der Loos C.M., Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994, 89:36-44.
57. Kovanen P.T., Kaartinen M., Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995, 92:1084-1088.
58. Laine P., Kaartinen M., Penttila A., Panula P., Paavonen T., Kovanen P.T. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 1999, 99:361-369.
59. Kaartinen M., van der Wal A.C., van der Loos C.M., et al. Mast cell infiltration in acute coronary syndromes: implications for plaque rupture. JAm Coll Cardiol 1998, 32:606-612.
60. Buffon A., Biasucci L.M., Liuzzo G., D'Onofrio G., Crea F., Maseri A. Widespread coronary inflammation in unstable angina. NEngl J Med 2002, 347:5-12.
61. Abbate A., Bonanno E., Mauriello A., et al. Widespread myocardial inflammation and infarct-related artery patency. Circulation 2004, 110:46-50.
62. Narducci M.L., Grasselli A., Biasucci L.M., et al. High telomerase activity in neutrophils from unstable coronary plaques. JAm Coll Cardiol 2007, 50:2369-2374.
63. Maugeri N., Rovere-Querini P., Evangelista V., et al. An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes. PLoS One 2012, 7. e39484.
64. Libby P., Nahrendorf M., Pittet M.J., Swirski F.K. Diversity of denizens of the atherosclerotic plaque: not all monocytes are created equal. Circulation 2008, 117:3168-3170.
65. Woollard K.J., Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 2010, 7:77-86.
66. Tsujioka H., Imanishi T., Ikejima H., et al. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. JAm Coll Cardiol 2009, 54:130-138.
67. Nikkari S.T., O'Brien K.D., Ferguson M., et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 1995, 92:1393-1398.
68. Xu X.P., Meisel S.R., Ong J.M., et al. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation 1999, 99:993-998.
69. Rajavashisth T.B., Xu X.P., Jovinge S., et al. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation 1999, 99:3103-3109.
70. Sukhova G.K., Schonbeck U., Rabkin E., et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999, 99:2503-2509.
71. Wyss C.A., Neidhart M., Altwegg L., et al. Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes. Eur Heart J 2010, 31:1457-1469.
72. Yonekawa K., Neidhart M., Altwegg L.A., et al. Myeloid related proteins activate Toll-like receptor 4 in human acute coronary syndromes. Atherosclerosis 2011, 218:486-492.
73. Niessner A., Shin M.S., Pryshchep O., Goronzy J.J., Chaikof E.L., Weyand C.M. Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation 2007, 116:2043-2052.
74. Blair P., Rex S., Vitseva O., et al. Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ Res 2009, 104:346-354.
75. Beaulieu L.M., Lin E., Morin K.M., Tanriverdi K., Freedman J.E. Regulatory effects of TLR2 on megakaryocytic cell function. Blood 2011, 117:5963-5974.
76. De Palma R., Del Galdo F., Abbate G., et al. Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologic mechanism. Circulation 2006, 113:640-646.
77. Nakajima T., Schulte S., Warrington K.J., et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002, 105:570-575.
78. Pryshchep S., Sato K., Goronzy J.J., Weyand C.M. Tcell recognition and killing of vascular smooth muscle cells in acute coronary syndrome. Circ Res 2006, 98:1168-1176.
79. Dumitriu I.E., Araguas E.T., Baboonian C., Kaski J.C. CD4+ CD28null T cells in coronary artery disease: when helpers become killers. Cardiovasc Res 2009, 81:11-19.
80. Zhang X., Niessner A., Nakajima T., et al. Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ Res 2006, 98:524-531.
81. Miossec P., Korn T., Kuchroo V.K. Interleukin-17 and type 17 helper T cells. NEngl J Med 2009, 361:888-898.
82. Ait-Oufella H., Salomon B.L., Potteaux S., et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006, 12:178-180.
83. Mai J., Wang H., Yang X.F. Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity. Front Biosci 2010, 15:986-1006.
84. Mor A., Luboshits G., Planer D., Keren G., George J. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J 2006, 27:2530-2537.
85. Zhu F., Wang Q., Guo C., et al. IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome. Clin Immunol 2011, 141:152-160.
86. Liuzzo G., Montone R.A., Gabriele M., et al. Identification of unique adaptive immune system signature in acute coronary syndromes. Int J Cardiol 2013, 168(1):564-567.
87. Newby D.E. Triggering of acute myocardial infarction: beyond the vulnerable plaque. Heart 2010, 96:1247-1251.
88. Thrall G., Lane D., Carroll D., Lip G.Y. Asystematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: Implications for the pathogenesis of acute coronary syndromes. Thromb Res 2007, 120:819-847.
89. Richardson P.D., Davies M.J., Born G.V. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989, 2:941-944.
90. Abela G.S., Aziz K., Vedre A., Pathak D.R., Talbott J.D., Dejong J. Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes. Am J Cardiol 2009, 103:959-968.
91. Tziakas D.N., Kaski J.C., Chalikias G.K., et al. Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability?. JAm Coll Cardiol 2007, 49:2081-2089.
92. Arbustini E., Dal Bello B., Morbini P., et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 1999, 82:269-272.
93. Ferrante G., Nakano M., Prati F., et al. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation 2010, 122:2505-2513.
94. Kolodgie F.D., Burke A.P., Farb A., et al. Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol 2002, 22:1642-1648.
95. Sakai T., Inoue S., Takei M., et al. Activated inflammatory cells participate in thrombus size through tissue factor and plasminogen activator inhibitor-1 in acute coronary syndrome: Immunohistochemical analysis. Thromb Res 2011, 127:443-449.
96. Yunoki K., Naruko T., Sugioka K., et al. Erythrocyte-rich thrombus aspirated from patients with ST-elevation myocardial infarction: association with oxidative stress and its impact on myocardial reperfusion. Eur Heart J 2012, 33:1480-1490.
97. Niccoli G., Giubilato S., Di Vito L., et al. Severity of coronary atherosclerosis in patients with a first acute coronary event: a diabetes paradox. Eur Heart J 2013, 34:729-741.
98. Ong P., Athanasiadis A., Hill S., Vogelsberg H., Voehringer M., Sechtem U. Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (Coronary Artery Spasm in Patients with Acute Coronary Syndrome) Study. JAm Coll Cardiol 2008, 52:523-527.
99. Shimokawa H., Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 2005, 25:1767-1775.
100. Lanza G.A., Careri G., Crea F. Mechanisms of coronary artery spasm. Circulation 2011, 124:1774-1782.
101. Funayama A., Watanabe T., Tamabuchi T., et al. Elevated cystatin C levels predict the incidence of vasospastic angina. Circ J 2011, 75:2439-2444.
102. Camici P.G., Crea F. Coronary microvascular dysfunction. NEngl J Med 2007, 356:830-840.
103. Lanza G.A., Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation 2010, 121:2317-2325.
104. Galiuto L., De Caterina A.R., Porfidia A., et al. Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in Apical Ballooning or Tako-Tsubo Syndrome. Eur Heart J 2010, 31:1319-1327.
105. Mohri M., Koyanagi M., Egashira K., et al. Angina pectoris caused by coronary microvascular spasm. Lancet 1998, 351:1165-1169.
106. Roe M.T., Armstrong P.W., Fox K.A., et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. NEngl J Med 2012, 367:1297-1309.
107. Alexander J.H., Lopes R.D., James S., et al. for the APPRAISE-2 Investigators. Apixaban with antiplatelet therapy after acute coronary syndrome. NEngl J Med 2011, 365:699-708.
108. Kaski J.C. C-reactive protein improves risk prediction in patients with acute coronary syndrome, or does it?. Eur Heart J 2010, 31:274-277.
109. Braunwald E. Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials. Eur Heart J 2012, 33:430-432.
110. Bona R.D., Liuzzo G., Pedicino D., Crea F. Anti-inflammatory treatment of acute coronary syndromes. Curr Pharm Des 2011, 17:4172-4189.
111. Ridker P.M. Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT). JThromb Haemost 2009, 7Suppl(1):332-339.
112. Versaci F., Gaspardone A., Tomai F., et al. Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS Study). JAm Coll Cardiol 2002, 40:1935-1942.
113. +CD28null T lymphocytes by tumor necrosis factor-α blockade in patients with unstable angina. Circulation 2006, 113:2272-2277.
114. Brugaletta S., Biasucci L.M., Pinnelli M., et al. Novel anti-inflammatory effect of statins: reduction of CD4+CD28null T lymphocyte frequency in patients with unstable angina. Heart 2006, 92:249-250.
115. Nissen S.E. High-dose statins in acute coronary syndromes: not just lipid levels. JAm Med Assoc 2004, 292:1365-1367.
116. Abbate A., Kontos M.C., Grizzard J.D., et al. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). Am J Cardiol 2010, 105:1371-1377.
117. Putnam A.L., Brusko T.M., Lee M.R., et al. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 2009, 58:652-662.
118. Serruys P.W., García-García H.M., Buszman P., et al. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 2008, 118:1172-1182.
119. Nicholls S.J., Cavender M.A., Kastelein J.J., et al. Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial. Cardiovasc Drugs Ther 2012, 26:71-75.
120. Holmes M.V., Simon T., Exeter H.J., et al. Secretory phospholipase A2-IIA and cardiovascular disease: a Mendelian randomization study. JAm Coll Cardiol 2013, 62:1966-1976.
121. Saeed O., Otsuka F., Polavarapu R., et al. Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis. Arterioscler Thromb Vasc Biol 2012, 32:299-307.
122. Ronald J.A., Chen J.W., Chen Y., et al. Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques. Circulation 2009, 120:592-599.
123. Kikuchi Y., Yasuda S., Aizawa K., et al. Enhanced Rho-kinase activity in circulating neutrophils of patients with vasospastic angina: a possible biomarker for diagnosis and disease activity assessment. JAm Coll Cardiol 2011, 58:1231-1237.
124. Masumoto A., Mohri M., Shimokawa H., Urakami L., Usui M., Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 2002, 105:1545-1547.
125. Dias A., Franco E., Mercedes A., Hebert K., Messina D., Quevedo H.C. Clinical features of takotsubo cardiomyopathy - a single-center experience. Cardiology 2013, 126:126-130.